Close button
Enquiry IconContact Us
Logo
  • Choose License Type

Global Orthopedic Regenerative Medicine Market, by Treatment Type (Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting), Plasma Based Therapy, Tissue Engineering (Allograft)), by Disease Indication (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Bursitis, and Osteoporosis), by End User (Hospital and Clinics, Orthopedic Specialty Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 7,774.7 million in 2021 and is expected to exhibit a CAGR of 10.8% during the forecast period (2021-2028).

Market players are indulged in receiving approvals for orthopedic technologies from the regulatory authorities for the treatment of orthopedic issues, which is expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, on December 17, 2020, the U.S. Food and Drug Administration issued approval for SwiveLock ACL Repair Kit, which was launched by Arthex, a manufacturer of orthopedic surgical devices. This Kit was developed for primary repairing of Anterior Cruciate Ligament (ACL) tear and it contains all the convenient surgical products needed for ACL repair technique.

Regulatory authorities and government organizations are indulged in developing new guidelines for market players to receive designation for investigational drug, which is expected to drive the growth of the global orthopedic regenerative medicine market. For instance, in February 2019, the U.S. Food and Drug Administration (FDA) issued guidelines for designation program to receive Regenerative Medicine Advanced Therapy (RMAT) approval for new investigational drug. This guidelines states that the drug should be developed using a proper definition of regenerative medicine, effective in the treatment for serious illness and that can be modified as per need. The preliminary clinical evidences should indicate the potential of the regenerative medicine therapy to address the medical need of diseases. Market companies will gain approval for regenerative medicine if they follow these requirements.

Global Orthopedic Regenerative Medicine Market - Impact of Coronavirus (COVID – 19) Pandemic

The coronavirus disease (COVID-19) pandemic is expected to drive growth of the global orthopedic regenerative medicine market over the forecast period. COVID-19 is the most recent pandemic outbreak which was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020. According to the World Health Organization (WHO) Weekly epidemiological update on COVID-19, the number of new cases and deaths continued to decrease, with nearly 265 million cases of COVID-19 were reported globally and with just under 5,254,116 deaths till December 5, 2021.

Increasing research and development activities by the market players is expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, in August 2018, Curasan AG, a manufacturer and developer of medical devices and β-TCP techniques for repairing damaged tissues and bone, developed Ortho Foam Strip, a collagen scaffold which contains silicate doping that allows osteoconductivity with physiological resorption of biomimetic scaffold which leads to full bone regeneration.

Browse 36 Market Data Tables and 42 Figures spread through 197 Pages and in-depth TOC on Global Orthopedic Regenerative Medicine by Treatment Type (Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting), Plasma Based Therapy, Tissue Engineering (Allograft)), by Disease Indication (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Bursitis, and Osteoporosis), by End User (Hospital and Clinics, Orthopedic Specialty Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

To know the latest trends and insights prevalent in the orthopedic regenerative medicine market, click the link below:

https://www.coherentmarketinsights.com/market-insight/orthopedic-regenerative-medicine-market-4841

Increasing prevalence of musculoskeletal disorders globally is expected to drive the growth of the global orthopedic regenerative medicine market, over the forecast period. For instance, according to the fact sheet published on February 8 ,2021, by the World Health Organization (WHO), 1.71 billion people worldwide were suffering from musculoskeletal disorders, with high-income countries such as the U.S., Australia, and others having highest number of people affected at 441 million, followed by western pacific region with 427 million. The following pie chart indicates the percentage of population affected with musculoskeletal disorders.

Press Release Image

Key Takeaways of the Orthopedic Regenerative Medicine Market:

  • The global orthopedic regenerative medicine market is expected to exhibit a CAGR of 10.8% over the forecast period (2021-2028), owing to growth in potential markets, especially in Europe. While North America region accounted for the major market share for the year 2020.
  • Market players are involved in presenting their research at the conference to increase the product portfolio in market. On December 14, 2020, American Academy/ Association of Orthopedic Medicine (AAOM) conducted virtual conference to describe regulations and application of orthopedic regenerative therapies to market players and utilization of therapies of musculoskeletal disorders with scope of regenerative medicines.
  • Some of the major players operating in the global orthopedic regenerative medicine market include Ortho Regenerative Technologies Inc., Personalized stem cells Inc., Anika Therapeutics Inc., Arthrex Inc., Baxter International Inc., Conmed Corporation, Aziyo Biologics, Curasan Inc., Swiss biomed Orthopedics AG, Octane Medical Inc., Stryker Corporation, Carmell Therapeutics Corporation, Zimmer Holdings, Smith & Nephew plc., and NuVasive Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.